A comparison of three times vs. five times weekly narrowband ultraviolet B phototherapy for the treatment of chronic plaque psoriasis. 2010

Zahra Hallaji, and Masoumeh Barzegari, and Kamran Balighi, and Pouria Mansoori, and Arash Taheri, and Parisa Mansoori
Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran.

BACKGROUND Narrowband ultraviolet B (NB-UVB) phototherapy is an effective treatment for psoriasis. OBJECTIVE To compare the effects of three and five times weekly NB-UVB phototherapy in the treatment of chronic plaque psoriasis. METHODS Sixty-five patients with chronic plaque psoriasis were allocated to receive three or five times weekly NB-UVB, starting at low dose. RESULTS Among the patients who completed the study, clearance was achieved in 18 out of 23 patients (78%) in the three times weekly group and in 15 out of 22 patients (68%) in the five times weekly group. The difference was not statistically significant (P=0.44). No statistically significant differences were found between the two groups in the number of treatments (P=0.95), cumulative UVB dose (P=0.51), and rate of side-effects. Length of the treatment period was significantly shorter in the five times weekly group (P<0.001). At the end of treatment, the mean psoriasis area and severity index score was lower in the three times weekly group (P=0.02). CONCLUSIONS We recommend three times weekly NB-UVB for chronic plaque psoriasis; however, the more rapid clearance of psoriasis with five times weekly phototherapy may justify using this method in some patients.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011565 Psoriasis A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis. Palmoplantaris Pustulosis,Pustular Psoriasis of Palms and Soles,Pustulosis Palmaris et Plantaris,Pustulosis of Palms and Soles,Psoriases
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D004307 Dose-Response Relationship, Radiation The relationship between the dose of administered radiation and the response of the organism or tissue to the radiation. Dose Response Relationship, Radiation,Dose-Response Relationships, Radiation,Radiation Dose-Response Relationship,Radiation Dose-Response Relationships,Relationship, Radiation Dose-Response,Relationships, Radiation Dose-Response
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Zahra Hallaji, and Masoumeh Barzegari, and Kamran Balighi, and Pouria Mansoori, and Arash Taheri, and Parisa Mansoori
November 2002, The British journal of dermatology,
Zahra Hallaji, and Masoumeh Barzegari, and Kamran Balighi, and Pouria Mansoori, and Arash Taheri, and Parisa Mansoori
May 1998, The British journal of dermatology,
Zahra Hallaji, and Masoumeh Barzegari, and Kamran Balighi, and Pouria Mansoori, and Arash Taheri, and Parisa Mansoori
October 2006, Journal of the European Academy of Dermatology and Venereology : JEADV,
Zahra Hallaji, and Masoumeh Barzegari, and Kamran Balighi, and Pouria Mansoori, and Arash Taheri, and Parisa Mansoori
May 1999, Archives of dermatology,
Zahra Hallaji, and Masoumeh Barzegari, and Kamran Balighi, and Pouria Mansoori, and Arash Taheri, and Parisa Mansoori
August 2005, The Journal of dermatological treatment,
Zahra Hallaji, and Masoumeh Barzegari, and Kamran Balighi, and Pouria Mansoori, and Arash Taheri, and Parisa Mansoori
July 2013, The British journal of dermatology,
Zahra Hallaji, and Masoumeh Barzegari, and Kamran Balighi, and Pouria Mansoori, and Arash Taheri, and Parisa Mansoori
July 2013, The British journal of dermatology,
Zahra Hallaji, and Masoumeh Barzegari, and Kamran Balighi, and Pouria Mansoori, and Arash Taheri, and Parisa Mansoori
December 2014, International journal of dermatology,
Zahra Hallaji, and Masoumeh Barzegari, and Kamran Balighi, and Pouria Mansoori, and Arash Taheri, and Parisa Mansoori
June 2006, Journal of the American Academy of Dermatology,
Zahra Hallaji, and Masoumeh Barzegari, and Kamran Balighi, and Pouria Mansoori, and Arash Taheri, and Parisa Mansoori
March 2003, Archives of dermatology,
Copied contents to your clipboard!